老板办公室乳摸GIF动态图,色婷婷亚洲一区二区三区,国产全是老熟女太爽了,欧美极度残忍变态另类电影
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Prospectus
Announcements
2022.03.30
Date of Board Meeting
2022.03.30
(1) DELAY IN PUBLICATION OF AUDITED ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR END...
2022.03.18
DATE OF BOARD MEETING
2022.03.15
“HEPARIN SODIUM ACTIVE PHARMACEUTICAL INGREDIENT AND ENOXAPARIN SODIUM ACTIVE PH...
2022.03.02
Monthly Return 月報表
2022.01.29
PROFIT WARNING ANNOUNCEMENT ON THE ESTIMATED DECREASE IN PROFIT FOR THE ANNUAL ...
2022.01.27
VOLUNTARY ANNOUNCEMENT LAUNCH OF HEPARIN SODIUM INJECTION IN THE USA
2022.01.04
Overseas Regulatory Announcement
2022.01.04
POLL RESULTS OF THE 2022 FIRST EXTRAORDINARY GENERAL MEETING HELD ON 4 JANUARY 2...
2021.12.13
Notification Letter and Request Form to Non-Registered Shareholders
第一頁
上一頁
8
9
10
11
12
下一頁
最后一頁
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.